KR
Krsnaa Diagnostics Ltd (KRSNAA)
₹555.65
Mkt cap
₹1,755 Cr
P/E ratio
17.70
P/B
1.82
Div yield
0.37%
ROE
10.90%
ROCE
12.70%
EPS (TTM)
₹31.39
Book value
₹306
52W range
515–848
Sector
Healthcare
Price history
Previous close
Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns. [1]
NSE KRSNAABSE 543328
Health check
Constructive
ValuationCheap
ProfitabilityAverage
GrowthHigh
TechnicalsBearish
52-week range
−34.48% from high₹556
₹515+7.89% from low₹848
Current
₹555.65
Prev close
₹560.35
Day
−0.84%
Price performance
1D
−0.84%
1W
+4.04%
1M
+0.85%
3M
+0.82%
6M
+0.94%
1Y
−29.96%
YTD
−24.23%
Financials
Revenue, profit & margin
P/E ratio
17.7×
KRSNAA is 52% below the sector median of 36.5×
KRSNAA17.7×
Sector median36.5×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 132 | 147 | 152 | 159 | 163 | 179 | 165 | 175 | 176 | 183 | 159 | 173 | 211 | |
| Expenses | 100 | 116 | 113 | 116 | 120 | 126 | 117 | 121 | 126 | 125 | 112 | 116 | 154 | |
| Operating Profit | 32 | 31 | 38 | 43 | 43 | 52 | 48 | 53 | 50 | 58 | 48 | 57 | 57 | |
| OPM % | 24% | 21% | 25% | 27% | 26% | 29% | 29% | 31% | 29% | 32% | 30% | 33% | 27% | |
| Other Income | 4 | 4 | 4 | 4 | 7 | 5 | 9 | 4 | 4 | 4 | 4 | 31 | 7 | |
| Interest | 2 | 3 | 4 | 7 | 5 | 6 | 6 | 7 | 6 | 8 | 8 | 12 | 15 | |
| Depreciation | 16 | 18 | 21 | 18 | 21 | 22 | 23 | 22 | 22 | 23 | 23 | 22 | 28 | |
| Profit before tax | 19 | 14 | 17 | 22 | 24 | 28 | 28 | 29 | 26 | 31 | 21 | 54 | 22 | |
| Tax % | 18% | 20% | 20% | 17% | 23% | 23% | 24% | 28% | 26% | 24% | 22% | 20% | 26% | |
| Net Profit | 15 | 11 | 14 | 18 | 18 | 22 | 22 | 21 | 20 | 23 | 16 | 43 | 16 | |
| EPS in Rs | 4.86 | 3.60 | 4.21 | 5.70 | 5.63 | 6.80 | 6.69 | 6.53 | 6.03 | 7.16 | 5.08 | 13.37 | 4.88 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move +3.33% · closed higher next day 1 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 14 Aug '26 |
| Earnings day | +3.33% |
| +1 day | +0.31% |
| +5 days | +0.88% |
| +15 days | +0.58% |
| +30 days | −4.08% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jun 202627.11%Promoter
Promoters27.11%
FIIs4.28%0.37
DIIs14.51%0.62
Public54.08%1.01
Ownership trend
Peers
7 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Dr Lal Pathlabs | ₹1,896.90 | 56.63 | 31,839 | 0.74% | 171 | +28.02% | 798 | +19.10% | 28.00% |
| Vijaya Diagnost. | ₹1,558.90 | 85.64 | 16,056 | 0.13% | 53 | +37.60% | 231 | +22.83% | 20.53% |
| Metropolis Healt | ₹597.45 | 59.55 | 12,394 | 0.33% | 57 | +25.77% | 450 | +16.62% | 17.81% |
| Thyrocare Tech. | ₹555.80 | 48.95 | 8,846 | 1.68% | 51 | +34.06% | 240 | +24.34% | 35.38% |
| Nephrocare Health Services | ₹743.35 | 87.83 | 7,475 | 0.00% | 32 | +34.89% | 282 | +23.69% | 15.34% |
| Krsnaa Diagnost. | ₹541.15 | 17.74 | 1,755 | 0.37% | 16 | −19.12% | 211 | +19.95% | 12.70% |
| Suraksha Diagno. | ₹335.10 | 48.75 | 1,745 | 0.15% | 13 | +38.40% | 88 | +20.75% | 17.29% |
| Median: 17 Co. | ₹335.10 | 36.54 | 1,053 | 0.00% | 11 | +28.02% | 95 | +19.10% | 20.53% |
Filings
Annual reports6
Concall transcripts51
TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptMay 2026PPTMay 2026RECMay 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025PPTNov 2025TranscriptAug 2025PPTAug 2025TranscriptMay 2025PPTMay 2025TranscriptFeb 2025PPTFeb 2025TranscriptNov 2024PPTNov 2024PPTOct 2024TranscriptAug 2024PPTAug 2024
Credit ratings6
Announcements5
Closure of Trading Window 19 SepShareholder Meeting / Postal Ballot-Scrutinizer"s Report 18 SepDisclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Execution Of Concession Agreement For PET-CT Diagnostic Facilities In Punjab 16 Sep - Krsnaa executes 15-year PPP concession for PET-CT facilities at 4 Punjab hospitals.Intimation - Regulation 36(1)(B) Of The SEBI Listing Regulations 11 Sep - Krsnaa Diagnostics dispatched FY2025-26 annual report; 16th AGM scheduled for September 28, 2026.Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 9 Sep - CIT(A), Pune passed seven income-tax orders for AY2017-18 to AY2023-24; disputed demand totals ₹62.69 crore.